Bell Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Bell Investment Advisors's NVS Position: Q2 2026 in Review
Bell Investment Advisors reduced its Novartis (NVS) stake by 1.5% in Q2 2026, selling an estimated $600 and leaving 259 shares worth $40.6K. The position accounts for 0.01% of the portfolio, ranked #315.
Bell Investment Advisors first reported a position in NVS in Q3 2021 and has held it in 19 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Bell Investment Advisors held 259 shares of Novartis worth $40.6K as of Q2 2026.
- Bell Investment Advisors sold 4 Novartis shares in Q2 2026, an estimated $600.
- Novartis made up 0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #315 holding.
- Bell Investment Advisors first reported a position in Novartis in Q3 2021 and has held it in 19 quarters since.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.